Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-dose Ketamine to Reduce Pain Severity, Depressive Symptoms and the Need for Opiates Both During and After Emergency Department Care

NCT03436121 is registered in ClinicalTrials.gov with Maria Pacella as lead sponsor.

NCT NCT03436121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03436121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-dose Ketamine to Reduce Pain Severity, Depressive Symptoms and the Need for Opiates Both During and After Emergency Department Care
Lead sponsor
Maria Pacella
Phase
Phase 2/3
Overall status
Withdrawn
Start date
December 31, 2019
Completion date
February 5, 2020
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, depression